Kumar and coworkers employed CSF1R inhibition to disrupt chemokine secretion by cancer associated fibroblasts (CAF) abolishing recruitment of pro-tumor granulocytic myeloid-derived suppressor cells (MDSCs). The gene discussed is CSF1R; the disease is cancer.